Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-30

Clinical Trial Update: Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating aflibercept in patients with diabetic macular edema previously treated with ranibizumab or bevacizumab; study completed with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aflibercept (Aflibercept)

Snippet

Sponsor: Rishi Singh | Conditions: Diabetic Retinopathy, Macular Edema | Phase 4 | Status: COMPLETED | Results posted: 2023-03-30